Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Fajgenbaum

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|June 3, 2025
Expert Perspective: Diagnosis and Treatment of Castleman DiseaseLuke Y C Chen, Lu Zhang, David C Fajgenbaum
American Journal of Hematology|November 19, 2022
Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapyErtugrul Bayram, Umur Anil Pehlivan, David C Fajgenbaum, et al.
Bosnian Journal of Basic Medical Sciences|January 31, 2017
TAFRO syndrome: New subtype of idiopathic multicentric Castleman diseaseGordan Srkalovic, Inga Marijanovic, Maya B Srkalovic, et al.
The Lancet. Haematology|April 12, 2016
The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease researchDavid C Fajgenbaum, Jason R Ruth, Dermot Kelleher, et al.
Haematologica|April 29, 2022
The lymph node transcriptome of unicentric and idiopathic multicentric Castleman diseasePedro Horna, Rebecca L King, Dragan Jevremovic, et al.
The New England Journal of Medicine|May 25, 2022
Case 16-2022: A 55-Year-Old Man with Fevers, Night Sweats, and a Mediastinal MassDavid C Fajgenbaum, Reece J Goiffon, Jacob D Soumerai, et al.
Lancet (London, England)|May 9, 2021
Adrenalitis and anasarca in idiopathic multicentric Castleman's diseaseLuke Y C Chen, Brian F Skinnider, Don Wilson, et al.
Medicine|February 7, 2020
AA amyloidosis associated with Castleman disease: A case report and review of the literatureLuca Bernabei, Adam Waxman, Gabriel Caponetti, et al.
American Journal of Clinical Pathology|March 9, 2026
How I diagnose Castleman diseaseDorottya Laczko, Vinodh Pillai, Dale Frank, et al.
Blood Advances|September 17, 2021
Epidemiology and treatment patterns of idiopathic multicentric Castleman disease in the era of IL-6-directed therapySudipto Mukherjee, Rabecka Martin, Brenda Sande, et al.
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Arthritis & Rheumatology (Hoboken, N.J.)|June 3, 2025
Expert Perspective: Diagnosis and Treatment of Castleman DiseaseLuke Y C Chen, Lu Zhang, David C Fajgenbaum
American Journal of Hematology|November 19, 2022
Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapyErtugrul Bayram, Umur Anil Pehlivan, David C Fajgenbaum, et al.
Bosnian Journal of Basic Medical Sciences|January 31, 2017
TAFRO syndrome: New subtype of idiopathic multicentric Castleman diseaseGordan Srkalovic, Inga Marijanovic, Maya B Srkalovic, et al.
The Lancet. Haematology|April 12, 2016
The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease researchDavid C Fajgenbaum, Jason R Ruth, Dermot Kelleher, et al.
Haematologica|April 29, 2022
The lymph node transcriptome of unicentric and idiopathic multicentric Castleman diseasePedro Horna, Rebecca L King, Dragan Jevremovic, et al.
The New England Journal of Medicine|May 25, 2022
Case 16-2022: A 55-Year-Old Man with Fevers, Night Sweats, and a Mediastinal MassDavid C Fajgenbaum, Reece J Goiffon, Jacob D Soumerai, et al.
Lancet (London, England)|May 9, 2021
Adrenalitis and anasarca in idiopathic multicentric Castleman's diseaseLuke Y C Chen, Brian F Skinnider, Don Wilson, et al.
Medicine|February 7, 2020
AA amyloidosis associated with Castleman disease: A case report and review of the literatureLuca Bernabei, Adam Waxman, Gabriel Caponetti, et al.
American Journal of Clinical Pathology|March 9, 2026
How I diagnose Castleman diseaseDorottya Laczko, Vinodh Pillai, Dale Frank, et al.
Blood Advances|September 17, 2021
Epidemiology and treatment patterns of idiopathic multicentric Castleman disease in the era of IL-6-directed therapySudipto Mukherjee, Rabecka Martin, Brenda Sande, et al.
Pageof 12